Understanding how pancreatic delta cells function in diabetes
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction
This study is looking at how certain cells in the pancreas that help control hormone release get affected in type 2 diabetes, with the goal of finding new ways to help manage blood sugar levels for people living with the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11037995 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that regulate the function of pancreatic delta cells, which are crucial for hormone secretion in response to glucose levels. It focuses on how these cells lose their ability to secrete somatostatin in type-2 diabetes, affecting insulin and glucagon release. The study employs animal models and examines the role of calcium signaling in delta cell function, aiming to uncover the changes that occur in diabetes. By understanding these processes, the research seeks to identify potential therapeutic targets for improving glucose regulation in diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type-2 diabetes who experience difficulties in blood glucose regulation.
Not a fit: Patients with type-1 diabetes or those without any form of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore proper hormone secretion and improve blood sugar control in patients with type-2 diabetes.
How similar studies have performed: Other research has shown promising results in understanding pancreatic cell function, but this specific approach to delta cell mechanisms in diabetes is relatively novel.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Jacobson, David Aaron — Vanderbilt University
- Study coordinator: Jacobson, David Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.